C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/18 (2006.01) C12N 5/071 (2010.01) A61K 31/7088 (2006.01) A61K 35/12 (2006.01) A61K 38/18 (2006.01) A61K 39/395 (2006.01) A61K 47/48 (2006.01) A61L 27/28 (2006.01) A61L 27/38 (2006.01) C07K 14/475 (2006.01) C12N 7/00 (2006.01) C12N 15/867 (2006.01)
Patent
CA 2730710
The present invention relates to the field of therapeutic use of proteins, genes and cells, in particular to the therapy based on the biological function of a secreted therapeutic protein, METRNL, in particular for the treatment of disorders of the ner-vous system. METRNL is a Nerve Survival and Growth factor with neuroprotective and/or neurogenesis effects.
La présente invention concerne le domaine de l'utilisation thérapeutique de protéines, de gènes et de cellules. L'invention porte plus particulièrement sur la thérapie basée sur la fonction biologique d'une protéine thérapeutique secrétée, METRNL, notamment dans le traitement de troubles du système nerveux. METRNL est un facteur de croissance et de survie des cellules nerveuses qui présente des effets neuroprotecteurs et/ou de neurogenèse.
Andrade Nuno Miguel Gomes
Fjord-Larsen Lone
Johansen Teit E.
Jorgensen Jesper Roland
Wahlberg Lars Ulrik
Gowling Lafleur Henderson Llp
Nsgene A/s
LandOfFree
Therapeutic use of a growth factor, metrnl does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic use of a growth factor, metrnl, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic use of a growth factor, metrnl will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1902869